Skip to main content

Jonathan Edelman

Senior Vice President, Vaccines Innovation Unit (VIU)

Dr. Jonathan Edelman
Jonathan Edelman
Dr. Jonathan Edelman is Senior Vice President, Vaccines Innovation Unit (VIU). In this role, Jon oversees research, clinical development, and program leadership related to vaccines, including the existing CSL Seqirus product portfolio and future vaccine innovations. Prior to his appointment, Jon was the Vice President of Clinical Development at CSL Seqirus, responsible for the company’s clinical research on a wide portfolio of influenza vaccines. 

Jon has more than 27 years of experience in the pharmaceutical industry. He received his bachelor degree in 1979 from Princeton University and his medical degree from the Mt. Sinai School of Medicine in 1983. 
Seqirus privacy statement
Seqirus privacy statement

This website contains content which is for New Zealand healthcare professionals only. By selecting this box you acknowledge that you are a new Zealand healthcare professional and accessing this website within the scope of your daily practice.